By Anette Breind, BioWorld Insight

For Academia or Industry In the private space, Charlottesville, Va.-based Biovista Inc…Biovista has a positioning program that uses a bioinformatics approach to “develop all reasonable opportunities” for a drug, Persidis said, by tracking “without bias,” all biological effects of a compound…But Biovista is also developing its own in-house pipeline of existing drugs for new indications, and the company puts less emphasis on the existing drugs’ IP than one might expect

Read More…